KUALA LUMPUR, Jan 7 (Bernama) -- Bursa Malaysia’s benchmark index rebounded from earlier losses to close at its intraday high on Wednesday, gaining 0.27 per cent in late trading as buying interest returned to selected heavyweights. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) advanced 4.48 points to 1,676.83 from Tuesday’s close of 1,672.35. The benchmark index opened 0.88 of-a-point lower at 1,671.47 and subsequently hit a low of 1,665.94 during the mid-morning session before gaining momentum toward closing. On the broader market, losers led gainers by 565 to 512, while some 526 counters were unchanged, 1,046 untraded, and 10 suspended. Turnover improved to 2.73 billion units worth RM2.76 billion versus Tuesday’s 2.66 billion units worth RM2.76 billion. Dealers said that investors were cautious following geopolitical developments in Asia.
Maintain perform with higher target price (TP) of RM4.38
9M16 core PATAMI of RM110.8m (+2.5% YoY) came in within expectations at 72% and 79% of our and consensus full-year forecasts. Maintain MARKET PERFORM and target price of RM4.38 based on unchanged 27x FY17E EPS.
Within expectations. 9M16 core PATAMI of RM110.8m (+59% YoY) came in within expectations at 72% and 79% of our and consensus full-year forecasts after excluding a one-off provision for ESOS payments (RM13.8m). A third interim single-tier DPS of 1.5 sen was declared, bringing 9M16 DPS to 4.8 sen which is within our expectation.
Key Result Highlights
QoQ, 3Q16 top line came flat at RM767m driven by lower outpatients volume (-2%) but mitigated by higher inpatients (+3%). Revenue growth came from new hospitals, namely KPJ Kuantan, KPJ Klang, KPJ Rawang, KPJ Pasir Gudang and KPJ Maharani and organic growth from existing operating units. However, 3Q16 core PATAMI fell 15% to RM32.8m compared to RM38m in 2Q16 (excluding a one-of provision for ESOS payment in 2Q16 of RM7.7m in 2Q16). Indonesia went back into the red recording a small loss of RM1m after registering two consecutive quarterly earnings, in line with lower revenue (- 25%).
YoY, 9M16 revenue rose 6% contributed by the increase in revenue from the new hospitals, namely KPJ Kuatan, KPJ Klang, KPJ Rawang, KPJ Pasir Gudang and KPJ Maharani and organic growth from existing operating units. This brings 9M16 core PATAMI to RM110.8m (+2.5% YoY) after excluding a oneoff provision for ESOS payments (RM13.8m).
Outlook. Earnings growth is expected to be pedestrian over the next few quarters. In Indonesia, there are plans to acquire an operator with a 150-bed private hospital. Elsewhere, we expect losses in Bumi Serpong Damai to persist over the next several quarters due to difficulty in attracting doctors to its establishment leading to lower bed utilisation of 40%. KPJ Pahang has just commenced operations this month. Going forward, KPJ is targeting to open KPJ Perlis and KPJ Pahang Specialist.
Maintain MARKET PERFORM and target price of RM4.38 based on unchanged 27x FY17E EPS.
Source: Kenanga Research - 01 December 2016
Comments
Post a Comment